Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Sell
24,518
-805
-3% -$17.8K ﹤0.01% 932
2026
Q1
$370K Sell
25,323
-6,311
-20% -$92.6K ﹤0.01% 1226
2025
Q4
$400K Buy
31,634
+972
+3% +$14.3K ﹤0.01% 1266
2025
Q3
$472K Sell
30,662
-5,276
-15% -$85K ﹤0.01% 1144
2025
Q2
$565K Sell
35,938
-1,635
-4% -$24.8K ﹤0.01% 1058
2025
Q1
$718K Sell
37,573
-10,463
-22% -$229K ﹤0.01% 928
2024
Q4
$1.15M Buy
48,036
+19,711
+70% +$550K ﹤0.01% 857
2024
Q3
$793K Buy
28,325
+10,401
+58% +$294K ﹤0.01% 882
2024
Q2
$469K Sell
17,924
-6,327
-26% -$132K ﹤0.01% 1019
2024
Q1
$530K Buy
24,251
+1,612
+7% +$34.5K ﹤0.01% 1045
2023
Q4
$527K Buy
22,639
+4,182
+23% +$84.1K ﹤0.01% 1009
2023
Q3
$364K Sell
18,457
-460
-2% -$9.06K ﹤0.01% 1096
2023
Q2
$429K Buy
+18,917
New +$381K ﹤0.01% 1039

Other funds holding RXO

ProShare Advisors's RXO Position: Q2 2026 in Review

ProShare Advisors reduced its RXO (RXO) stake by 3.2% in Q2 2026, selling an estimated $17.8K and leaving 24,518 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

ProShare Advisors first reported a position in RXO in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.15M in Q4 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • ProShare Advisors held 24,518 shares of RXO worth $676K as of Q2 2026.
  • ProShare Advisors sold 805 RXO shares in Q2 2026, an estimated $17.8K.
  • RXO made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #932 holding.
  • ProShare Advisors first reported a position in RXO in Q2 2023 and has held it in 13 quarters since.
  • ProShare Advisors's RXO position peaked at $1.15M in Q4 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.